A Phase I/II Clinical Study of LBL-034 in Patients With Relapsed/Refractory Multiple Myeloma

Condition:   Relapsed/Refractory Multiple Myeloma Intervention:   Drug: LBL-034 for Injection Sponsor:   Nanjing Leads Biolabs Co.,Ltd Not yet recruiting

Source: ClinicalTrials.gov - September 22, 2023 Category: Research Source Type: clinical trials